Join
Live feed
·
INSIDERFilingvia Quantisnow
Quoin Pharmaceuticals Ltd. logo

Director Culverwell Anthony James bought $45,000 worth of Ordinary Shares (100,000 units at $0.45), increasing direct ownership by 31,546% to 100,317 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track QNRX (Quoin Pharmaceuticals Ltd.) and more on Quantisnow.